Regulation of immunological checkpoints in human mesenchymal stromal cells (2019) Strauch V, Saul D, Mackensen A, Jitschin R, Mougiakakos D Conference contribution AML-derived exosomes promote induction of myeloid-derived suppressor cells in an mTOR-signaling-dependent fashion (2019) Jitschin R, Tohumeken S, Saul D, Bruns H, Braun M, Mackensen A, Mougiakakos D Conference contribution Oxidative stress upon allogeneic hematopoietic stem cell transplantation and its impact on the reconstituting immune system (2019) Karl F, Böttcher-Loschinski R, Stoll A, Rösler W, Mackensen A, Mougiakakos D, Völkl S Conference contribution Human monocytes display different levels of CD137/4-1BB expression linked to certain immunometabolic features (2019) Stoll A, Bruns H, Saul D, Mackensen A, Mougiakakos D Conference contribution Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO Study (2019) Goebell P, Hermann E, Kube U, Doehn C, Marschner N, Dietel A, Blumenstengel K, et al. Journal article Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options (2019) Ahrens M, Scheich S, Hartmann A, Bergmann L Journal article, Review article Barriers to using a nationwide skin cancer screening program: Findings from Germany (2018) Goerig T, Schneider S, Schilling L, Diehl K Journal article Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study (2018) Schochter F, Rack B, Tzschaschel M, Polasik A, Andergassen U, Trapp E, Alunni-Fabbroni M, et al. Journal article Reliability of determining the resectability of locally progressed pancreatic ductal adenocarcinomas - results from the CONKO-007 multicenter randomized controlled trial (EudraCT:2009-014476-21) (2018) Wittel UA, Golcher H, Gruetzmann R, Bechstein WO, Belyaev O, Uhl W, Ghadimi M, et al. Conference contribution Radiosensitizing and radioprotecting effect of kinase-inhibitor Palbociclib in different normal tissue and cancer cell lines (2018) Jost T, Hecht M, Fietkau R, Distel L Conference contribution